Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1956 1
1960 2
1961 3
1962 1
1963 2
1964 2
1965 1
1966 1
1968 1
1969 3
1970 3
1971 2
1972 3
1973 2
1974 4
1975 4
1976 4
1977 2
1978 3
1979 4
1980 7
1981 5
1982 7
1983 2
1984 5
1985 5
1986 6
1987 6
1988 6
1989 8
1990 5
1991 6
1992 3
1993 5
1994 3
1995 2
1996 1
1997 1
1998 5
2000 1
2001 2
2002 2
2003 4
2004 1
2005 4
2006 1
2007 1
2008 2
2009 1
2010 3
2011 5
2012 1
2013 5
2014 5
2015 5
2016 1
2017 4
2018 5
2019 5
2020 11
2021 11
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

214 results

Results by year

Filters applied: . Clear all
Page 1
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ; CLEAR Outcomes Investigators. Nissen SE, et al. N Engl J Med. 2023 Apr 13;388(15):1353-1364. doi: 10.1056/NEJMoa2215024. Epub 2023 Mar 4. N Engl J Med. 2023. PMID: 36876740 Clinical Trial.
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS; DECLARE–TIMI 58 Investigators. Wiviott SD, et al. N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415602 Clinical Trial.
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Bhatt DL, et al. N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415628 Clinical Trial.
Long-term use of ticagrelor in patients with prior myocardial infarction.
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; PEGASUS-TIMI 54 Steering Committee and Investigators. Bonaca MP, et al. N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14. N Engl J Med. 2015. PMID: 25773268 Free article. Clinical Trial.
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Verma S, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Dhingra NK, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Mason RP, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Verma S, et al. Circulation. 2021 Dec 7;144(23):1845-1855. doi: 10.1161/CIRCULATIONAHA.121.056290. Epub 2021 Oct 28. Circulation. 2021. PMID: 34710343 Free article. Clinical Trial.
Nutrition and metabolism.
Konstantinov VO. Konstantinov VO. Curr Opin Lipidol. 2003 Dec;14(6):631-3. doi: 10.1097/00041433-200312000-00012. Curr Opin Lipidol. 2003. PMID: 14624140 No abstract available.
Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Ridderstråle W, Leonsson-Zachrisson M, Liu Y, Opolski G, Zateyshchikov D, Ge J, Nicolau JC, Corbalán R, Cornel JH, Widimský P, Leiter LA; THEMIS Steering Committee and Investigators. Steg PG, et al. N Engl J Med. 2019 Oct 3;381(14):1309-1320. doi: 10.1056/NEJMoa1908077. Epub 2019 Sep 1. N Engl J Med. 2019. PMID: 31475798 Free article. Clinical Trial.
COVID-19 Fear in Eastern Europe: Validation of the Fear of COVID-19 Scale.
Reznik A, Gritsenko V, Konstantinov V, Khamenka N, Isralowitz R. Reznik A, et al. Among authors: konstantinov v. Int J Ment Health Addict. 2021;19(5):1903-1908. doi: 10.1007/s11469-020-00283-3. Epub 2020 May 12. Int J Ment Health Addict. 2021. PMID: 32406404 Free PMC article.
Somatic burden in Russia during the COVID-19 pandemic.
Zolotareva A, Khegay A, Voevodina E, Kritsky I, Ibragimov R, Nizovskih N, Konstantinov V, Malenova A, Belasheva I, Khodyreva N, Preobrazhensky V, Azanova K, Sarapultseva L, Galimova A, Atamanova I, Kulik A, Neyaskina Y, Lapshin M, Mamonova M, Kadyrov R, Volkova E, Drachkova V, Seryy A, Kosheleva N, Osin E. Zolotareva A, et al. Among authors: konstantinov v. PLoS One. 2023 Mar 10;18(3):e0282345. doi: 10.1371/journal.pone.0282345. eCollection 2023. PLoS One. 2023. PMID: 36897839 Free PMC article.
214 results